Table 1 Patients’ characteristics
From: Cell free RNA detection of pancreatic cancer in pre diagnostic high risk and symptomatic patients
CEDAR discovery and training cohort (n = 153) | BCC validation cohort (n = 95) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Benign pancreas | Pancreatitis | IPMN | PDAC | Cancer other | Benign pancreas | Pancreatitis | IPMN | PDAC | Cancer other | |
N | 48 | 59 | 16 | 20 | 10 | 23 | 23 | 11 | 21 | 17 |
Sex p < 0.001 | ||||||||||
Female | 23 | 22 | 11 | 1 | 7 | 15 | 6 | 8 | 4 | 6 |
Male | 25 | 37 | 5 | 19 | 3 | 8 | 17 | 3 | 17 | 11 |
Race p = 0.275 | ||||||||||
White, non hispanic | 45 | 52 | 16 | 18 | 6 | 22 | 22 | 11 | 20 | 17 |
Non white OR hispanic | 3 | 7 | 0 | 2 | 4 | 1 | 1 | 0 | 1 | 0 |
Age, years p < 0.001 | ||||||||||
Median | 57.5 | 58 | 67 | 70 | 55.5 | 58 | 55 | 67 | 72 | 75 |
Range | 25–82 | 25–77 | 32–83 | 50–83 | 27–73 | 30–81 | 34–78 | 42–83 | 58–85 | 39–86 |
PDAC stage | ||||||||||
1 | 5 | 4 | ||||||||
2 | 2 | 3 | ||||||||
3 | 5 | 9 | ||||||||
4 | 8 | 5 | ||||||||
